SARS-CoV-2 vaccine development and how Brazil is contributing-Reference-Cited by-同舟云学术

SARS-CoV-2 vaccine development and how Brazil is contributing

Published:2021 Issue:1 suppl 1 Volume:44 Page:
ISSN:1678-4685
Container-title:Genetics and Molecular Biology
language:
Short-container-title:Genet. Mol. Biol.

Author:

Kanno Alex I.¹,Barbosa Mayra M.F.²,Moraes Luana²,Leite Luciana C.C.¹^ORCID

Affiliation:

1. Instituto Butantan, Brazil

2. Instituto Butantan, Brazil; Universidade de São Paulo, Brazil

Publisher

FapUNIFESP (SciELO)

Subject

Genetics,Molecular Biology

Link

http://www.scielo.br/pdf/gmb/v44n1s1/1415-4757-GMB-44-1-s1-e20200320.pdf

Reference64 articles.

1. Zika virus vaccines;Abbink P;Nat Rev Microbiol,2018

2. SARS-CoV-2 candidate vaccine ChAdOx1 nCoV-19 infection of human cell lines reveals a normal low range of viral backbone gene expression alongside very high levels of SARS-CoV-2 S glycoprotein expression;Abdulaziz A;Res Sq,2020

3. Development of novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs;Alonso-Padilla J;Mol Ther,2016

4. Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen;Alves R;Clin Vaccine Immunol,2016

5. Vaccination greatly reduces disease, disability, death and inequity worldwide;Andre FE;Bull World Health Organ,2008

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An overview on recent patents and technologies on nanoparticles for nucleic acid delivery;Expert Opinion on Therapeutic Patents;2024-03-03

2. Dependency, Capacity, and Agency: Austerity and Leadership Failures in Brazil’s Homegrown COVID-19 Vaccine Efforts;Studies in Comparative International Development;2023-09

3. Produção científica latino-americana sobre produtos à base de nanotecnologia para o enfrentamento da COVID-19: uma revisão de escopo;Vigilância Sanitária em Debate;2023-02-27

4. Covid-19 Outbreak in Brazil: Health, Social, Political, and Economic Implications;International Journal of Health Services;2022-09-04

5. A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines;DARU Journal of Pharmaceutical Sciences;2022-09-02